Anti-human epithelial antigen, (Ber-EP4) helps define basal cell Carcinoma masked by inflammation

Dermatologic Surgery

Volumn 23, Issue 11, 1997, Pages 1067-1070

  Kist, David ^a   Perkins, William ^b   Christ, Suzanne ^c   Zachary, Christopher B ^c  

^a Office of Dr Ronald Moy   (United States)

^b NOTTINGHAM UNIVERSITY HOSPITALS NHS TRUST   (United Kingdom)

^c UNIVERSITY OF MINNESOTA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPITHELIAL MEMBRANE ANTIGEN;

ANTIGEN DETECTION; ARTICLE; BASAL CELL CARCINOMA; CHEMOSURGERY; CLINICAL ARTICLE; CONTROLLED STUDY; FROZEN SECTION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL;

EID: 0030730910     PISSN: 10760512     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1524-4725.1997.tb00449.x     Document Type: Article

References (18)

1. Rowe DE, Carroll RJ, Day CL Jr. Long-term recurrence rates in previously untreated (primary) basal cell carcinoma: Implications for patient follow-up. J Dermatol Surg Oncol 1989;15:315-28.
2. Rowe DE, Carroll RJ, Day CL Jr. Mohs surgery is the treatment of choice for recurrent (previously treated) basal cell carcinoma. J Dermatol Surg Oncol 1989;15:424-31.
3. Tromovitch TA, Stegman SJ. Microscopically controlled excision of skin tumors; chemosurgery (Mohs): fresh tissue technique. Arch Dermatol 1974;110:231-2.
4. Robinson JK, Gottschalk R. Immunofluorescent and immunoperoxidase staining of antibodies to fibrous keratin. Arch Dermatol 1984;120:199-203.
5. Zachary CB, Rest EB, Furlong SM, Arcedo PNC, McGeorge BCL, Kist DA. Rapid cytokeratin stains enhance the sensitivity of Mohs micrographic surgery for squamous cell carcinoma. J Dermatol Surg Oncol 1994;20:530-5.
6. Momburg F, Moldenhauer G, Hammerling GJ, Moller P. Immunohistochemical study of the expression of a Mw 34,000 human epithelium-specific surface glycoprotein in normal and malignant tissue. Cancer Res 1987;47:2883-91.
7. Moldenhauer G, Momburg F, Moller P, Schwartz R, Hammerling GJ. Epithelium-specific surface glycoprotein of Mr 34,000 is a widely distributed human carcinoma marker. Br J Cancer 1987; 56:714-21.
8. Latza U, Niedobitek G, Schwarting R, Nekarda H, Stein H. Ber-EP4: new monoclonal antibody which distinguishes epithelia from mesothelia. J Clin Pathol 1990;43:213-9.
9. Sheibani K, Shin SS, Keziran J, Weiss LM. Ber-EP4 antibody as a discriminant in the differential diagnosis of malignant mesothelioma versus adenocarcinoma. Am J Surg Pathol 1991;15:779-84.
10. Tellechea O, Reis JP, Domingues JC, Poiares Baptista A. Monoclonal antibody Ber-EP4 distinguishes basal cell carcinoma from squamous cell carcinoma of the skin. Am J Dermatopathol 1993; 15:452-5.
11. Markey AC, Birgitte Lane E, MacDonald DM, Leigh IM. Keratin expression in basal cell carcinomas. Br J Dermatol 1992;126:154-60.
12. Markey AC, Birgitte Lane E, Churchill LJ, MacDonald DM, Leigh IM. Expression of simple epithelial keratins 8 and 18 in epidermal neoplasia. J Invest Dermatol 1991;97:763-70.
13. Thomas P, Said JW, Nash G, Banks-Schlegel S. Profiles of keratin proteins in basal and squamous cell carcinomas of the skin. Lab Invest 1984;50:36-41.
14. Kooy AJW, Tank B, Vuzevski VD, Van Joost T. Expression of cytokeratin 8 and low molecular weight cytokeratins in human basal cell carcinoma. Anticancer Res 1995;15:241-8.
15. Habets JMW, Tank B, Vuzevski VD, Breve J, Stolz E, Van Joost T. Absence of cytokeratin 8 and inconsistent expression of cytokeratins 7 and 19 in human basal cell carcinoma. Anticancer Res 1988;8:611-6.
16. Moll R, Franke WW, Schiller DL, Geiger B, Krepler R. The catalog of human cytokeratins: Patterns of expression in normal epithelia, tumors and cultured cells. Cell 1982;31:11-24.
17. Ramnarain D, Walker NPJ. Rapid immunoperoxidase and immunofluorescence techniques using cytokeratin markers to assist in the diagnosis of basal cell carcinoma in Mohs micrographic surgery. Br J Dermatol 1991;125(Suppl):38.
18. Zachary CB, Rauch H, MacDonald DM. Shared Antigenic Determinants Between Cutaneous Structures and the Monoclonal Natural Killer cell Antibodies, Leu 7 and Leu 11. Clin Exp Derm 12:259-69.